Home
About
Overview
Sharing Data
ORCID
Help
History (2)
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis.
Sickle Cell Trait
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis.
Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 May 02; 390(17):1632.
View in:
PubMed
subject areas
Clinical Trials, Phase III as Topic
Humans
Iodide Peroxidase
Liver Cirrhosis
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Pyridazines
Thyroxine
authors with profiles
Amin Sabet MD